866-997-4948(US-Canada Toll Free)

Vascular Nanotransfer Technologies - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Dec 2012

Category :

Surgical Equipment

No. of Pages : 21 Pages


Vascular Nanotransfer Technologies (VNT) is a an medical technology company. It has developed a n innovative platform to develop proprietary Drug Coated Balloon (DCB). DCB\'s will be the ideal therapeutic tool for drug delivery in the patients with coronary in-stent restenosis (ISR) and peripheral vascular disease. The company is preparing DCB for a First-in-Man (F-I-M) clinical trial.VNT is headquartered in Auburndale, Massachusetts, the US.

This report is a source for data, analysis and actionable intelligence on the Vascular Nanotransfer Technologies portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Vascular Nanotransfer Technologies - Major Products and Services 5
Vascular Nanotransfer Technologies Pipeline Products by Equipment Type 6
Vascular Nanotransfer Technologies Pipeline Products by Development Stage 8
Vascular Nanotransfer Technologies Pipeline Products by Therapy Area 10
Vascular Nanotransfer Technologies Pipeline Products by Milestone Summary 12
Mitomycin-Based DCB - Coronary 13
Mitomycin-Based DCB - Coronary Product Status 13
Mitomycin-Based DCB - Coronary Product Description 13
Mitomycin-Based DCB - Peripheral 14
Mitomycin-Based DCB - Peripheral Product Status 14
Mitomycin-Based DCB - Peripheral Product Description 14
Paclitaxel-Based DCB - Coronary 15
Paclitaxel-Based DCB - Coronary Product Status 15
Paclitaxel-Based DCB - Coronary Product Description 15
Paclitaxel-Based DCB - Coronary Product Milestone 15
Paclitaxel-Based DCB - Peripheral 17
Paclitaxel-Based DCB - Peripheral Product Status 17
Paclitaxel-Based DCB - Peripheral Product Description 17
Vascular Nanotransfer Technologies - Key Employees 18
Vascular Nanotransfer Technologies - Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Vascular Nanotransfer Technologies, Recent Developments 20
Sep 12, 2012: Vascular Nanotransfer Technologies Appoints John Williams As CEO 20

Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Table


Vascular Nanotransfer Technologies, Key Facts 1
Vascular Nanotransfer Technologies Key Pipeline Products by Equipment Type 1
Vascular Nanotransfer Technologies Key Pipeline Products by Therapy Area 1
Vascular Nanotransfer Technologies Key Pipeline Products by Development Stage 1
Vascular Nanotransfer Technologies, Key Facts 4
Vascular Nanotransfer Technologies, Major Products and Services 5
Vascular Nanotransfer Technologies Number of Pipeline Products by Equipment Type 6
Vascular Nanotransfer Technologies Pipeline Products by Equipment Type 7
Vascular Nanotransfer Technologies Number of Pipeline Products by Development Stage 8
Vascular Nanotransfer Technologies Pipeline Products by Development Stage 9
Vascular Nanotransfer Technologies Number of Pipeline Products by Therapy Area 10
Vascular Nanotransfer Technologies Pipeline Products by Therapy Area 11
Vascular Nanotransfer Technologies Number of Pipeline Products By Milestone Summary 12
Vascular Nanotransfer Technologies Pipeline Products by Milestone Summary 12
Mitomycin-Based DCB - Coronary - Product Status 13
Mitomycin-Based DCB - Coronary - Product Description 13
Mitomycin-Based DCB - Peripheral - Product Status 14
Mitomycin-Based DCB - Peripheral - Product Description 14
Paclitaxel-Based DCB - Coronary - Product Status 15
Paclitaxel-Based DCB - Coronary - Product Description 15
Paclitaxel-Based DCB - Coronary - Product Milestone 15
Paclitaxel-Based DCB - Peripheral - Product Status 17
Paclitaxel-Based DCB - Peripheral - Product Description 17
Vascular Nanotransfer Technologies, Key Employees 18

List of Chart


Vascular Nanotransfer Technologies Pipeline Products by Equipment Type 6
Vascular Nanotransfer Technologies Pipeline Products by Development Stage 8
Vascular Nanotransfer Technologies Pipeline Products by Therapy Area 10
Vascular Nanotransfer Technologies Pipeline Products by Milestone Summary 12

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *